Cell Therapy: Optimizing The Vein-To-Vein Workflow

We are pleased to present you with this eBook on optimizing the vein-to-vein process for CAR T cell therapy, which has been produced by RegMedNet in association with Thermo Fisher Scientific. This eBook aims to bring you the latest developments and leading opinions from key thought leaders in the field.

The cell therapy workflow begins and ends at the patient and requires extensive infrastructure and coordination. At the beginning of the workflow, blood is collected directly from the patient and a tracking system is initiated for traceability. The patient material then undergoes processing to isolate the cell  type of choice, engineering of the cell to modify its functionality according to the therapeutic target, expansion of the cell population and then finally characterization and cryopreservation. Throughout this complex process, supply chain and logistical planning is necessary to ensure proper storage and transport of the material from start to finish.

In this eBook, we delve further into the cell therapy workflow and highlight the patient as a focal point throughout this journey. We also explore how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.